- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02840344
Couples-Based Mindfulness for Young Breast Cancer Survivors (C-MBSR)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
Columbia, Missouri, United States, 65201
- University of Missouri
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 years to 45 years old when diagnosed with breast cancer
- Diagnosed with stage 0, I, II, III breast cancer
- within 1 to 6 years after diagnosis of breast cancer
- Married or unmarried and living together.
- Living anywhere in the United States
- Both members of the couple must understand, read, and speak English
- Both members of the couple must have regular access to email and willingness to use the Internet.
Exclusion Criteria:
1. Neither members of the couple may be experienced meditators (20 minutes daily, 5 days a week or more, for over a year) or graduates of a former MBSR class.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Couples MBSR
Young breast cancer survivors and their partners take part in an 8-week Couples Mindfulness-Based Stress reduction (C-MBSR) intervention. The course will be taught through recorded videos of a trained MBSR instructor. The young breast cancer survivor and partner will be asked to watch a video module, together, each week for a total of 8 weeks. The C-MBSR course consists of practicing mindful stress reduction techniques and filling out handouts. Both members of the couple will be asked to complete surveys assessing primary and secondary outcome measures administered at baseline and after final session. Participants will be asked to provide a Salivary Cortisol sample at baseline and after the 8th session. Follow up Surveys will be administered at one and three months after intervention. |
Both members of the couple will be asked to participate in the weekly video sessions and activities.
|
|
Active Comparator: Individual MBSR
Young breast cancer survivors take part in an 8-week Individual Mindfulness-Based Stress reduction (I-MBSR) intervention. The course will be taught through recorded videos of a trained MBSR instructor. The young breast cancer survivor will be asked to watch a video module each week for 8 weeks in a row. The I-MBSR course consists of practicing mindful stress reduction techniques and filling out handouts. Both members of the couple will be asked to complete surveys assessing primary and secondary outcome measures administered at baseline and after final session. Participants will be asked to provide a Salivary Cortisol sample at baseline and after the 8th session. Follow up Surveys will be administered at one and three months after intervention. |
Only the young breast cancer survivor will participate in the weekly video sessions and activities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in couple functioning measured by the Measured by the Dyadic Adjustment Scale
Time Frame: Baseline to 6 months
|
The scale scores will be the average of items in the measure.
The scale scores will be averaged to create a summary score for each condition (no individual scores will be reported).
|
Baseline to 6 months
|
|
Change in couple functioning measured by the Measured by the Autonomy and Relatedness Inventory
Time Frame: Baseline to 6 months
|
The scale scores will be the average of items in the measure.
The scale scores will be averaged to create a summary score for each condition (no individual scores will be reported).
|
Baseline to 6 months
|
|
Change in couple functioning measured by the Sexual Interest and Satisfaction Scale
Time Frame: Baseline to 6 months
|
The scale scores will be the average of items in the measure.
The scale scores will be averaged to create a summary score for each condition (no individual scores will be reported).
|
Baseline to 6 months
|
|
Change in couple functioning measured by the Interpersonal Mindfulness Scale
Time Frame: Baseline to 6 months
|
The scale scores will be the average of items in the measure.
The scale scores will be averaged to create a summary score for each condition (no individual scores will be reported).
|
Baseline to 6 months
|
|
Perceived Partner Responsiveness
Time Frame: Baseline to 8 weeks
|
This scale will be measured each week for the 8 weeks of the intervention
|
Baseline to 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in anxiety scores measured by PROMIS -- Anxiety
Time Frame: Baseline to 6 months
|
The scale scores will be the average of items in the measure.
The scale scores will be averaged to create a summary score for each condition (no individual scores will be reported).
|
Baseline to 6 months
|
|
Change in depression scores measured by the PROMIS -- Depression
Time Frame: Baseline to 6 months
|
The scale scores will be the average of items in the measure.
The scale scores will be averaged to create a summary score for each condition (no individual scores will be reported).
|
Baseline to 6 months
|
|
Change in fatigue scores measured by PROMIS -- Fatigue
Time Frame: Baseline to 6 months
|
The scale scores will be the average of items in the measure.
The scale scores will be averaged to create a summary score for each condition (no individual scores will be reported).
|
Baseline to 6 months
|
|
Change in stress scores measured by the Perceived Stress Scale
Time Frame: Baseline to 6 months
|
The scale scores will be the average of items in the measure.
The scale scores will be averaged to create a summary score for each condition (no individual scores will be reported).
|
Baseline to 6 months
|
|
Changes in physical functioning measured by the PROMIS - Physical Function
Time Frame: Baseline to 6 months
|
The scale scores will be the average of items in the measure.
The scale scores will be averaged to create a summary score for each condition (no individual scores will be reported).
|
Baseline to 6 months
|
|
Changes in salivary cortisol biomarker to assess stress levels
Time Frame: Baseline to 8 weeks
|
Saliva will be analyzed for cortisol and summary scores will be calculated for each condition (no individual scores will be reported).
|
Baseline to 8 weeks
|
|
Changes in trait mindfulness measured by Mindful Attention and Awareness Scale
Time Frame: Baseline to 6 months
|
The scale scores will be the average of items in the measure.
The scale scores will be averaged to create a summary score for each condition (no individual scores will be reported).
|
Baseline to 6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ann Bettencourt, PhD, University of Missouri-Columbia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2003808
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
Clinical Trials on Couples MBSR
-
Beykoz UniversityUskudar University; Istanbul Nisantasi UniversityRecruitingAnxiety | Depression Anxiety DisorderTurkey
-
Virginia Commonwealth UniversityDepartment of Health and Human ServicesCompletedTraumatic Brain Injury | Acquired Brain InjuryUnited States
-
University of Notre DameEunice Kennedy Shriver National Institute of Child Health and Human Development...Active, not recruitingBehavior, InfantUnited States
-
University of California, San FranciscoUnknownHIV PreventionSouth Africa
-
Baylor College of MedicineNational Cancer Institute (NCI)Completed
-
Indiana UniversityIndiana University HealthCompletedChest Pain | Anxiety | MindfulnessUnited States
-
Emory UniversityNational Institute of Mental Health (NIMH)Completed
-
University of UtahNational Institute on Aging (NIA); University of Arizona; Banner HealthRecruitingSleep Apnea | Sleep DisturbanceUnited States
-
Ottawa Hospital Research InstituteCanadian Cancer Society (CCS)CompletedCancer | Chronic Pain | Painful Neuropathy | Worries; Pain or DisabilityCanada